Andrew Walsh's most recent trade in Annovis Bio Inc was a trade of 500 Common Stock done at an average price of $2.9 . Disclosure was reported to the exchange on June 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Annovis Bio Inc | Andrew Walsh | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 2.90 per share. | 16 Jun 2025 | 500 | 500 (0%) | 0% | 2.9 | 1,450 | Common Stock |